This may be associated with loss of GFAP expression in vivo, frequently found in high grade astrocytomas, although this event does not constitute a mandatory step in tumor development and it only represents the cell evolution towards an undifferentiated state. The gene discussed is GFAP; the disease is astrocytoma (excluding glioblastoma).